Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paweł Rubiś

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Polish Archives of Internal Medicine|September 29, 2025
Charting the genetic landscape of dilated cardiomyopathy in Poland: first insights from a national perspectivePaweł Rubiś
Cardiology|January 21, 2024
Pericardium in Stable and Decompensated Heart FailureEwa Dziewięcka, Paweł Rubiś
Kardiologia Polska|February 26, 2021
Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk ScoreEwa Dziewięcka, Paweł Rubiś
Przeglad Lekarski|September 26, 2007
[Heart failure and physical activity]Piotr Podolec, Paweł Rubiś
Polskie Archiwum Medycyny Wewnetrznej|August 23, 2003
[Cardiac involvement in systemic autoimmune disease]Jerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 24, 2003
Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarctionJerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś, et al.
Kardiologia Polska|September 29, 2009
Assessment of resting perfusion defect in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography with contrast-enhanced magnetic resonance imagingMaria Olszowska, Magdalena Kostkiewicz, Piotr Podolec, et al.
European Heart Journal. Case Reports|May 17, 2023
Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patientKrystian Mróz, Paweł Rubiś, Piotr Podolec, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 2, 2021
Sacubitril/valsartan for heart failure with reduced ejection fraction: A first real-life observational study in PolandMałgorzata Lelonek, Sylwia Wiśniowska-Śmiałek, Paweł Rubiś, et al.
Kardiologia Polska|January 17, 2024
Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac SocietyMałgorzata Lelonek, Agnieszka Pawlak, Ewa Straburzyńska-Migaj, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Polish Archives of Internal Medicine|September 29, 2025
Charting the genetic landscape of dilated cardiomyopathy in Poland: first insights from a national perspectivePaweł Rubiś
Cardiology|January 21, 2024
Pericardium in Stable and Decompensated Heart FailureEwa Dziewięcka, Paweł Rubiś
Kardiologia Polska|February 26, 2021
Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk ScoreEwa Dziewięcka, Paweł Rubiś
Przeglad Lekarski|September 26, 2007
[Heart failure and physical activity]Piotr Podolec, Paweł Rubiś
Polskie Archiwum Medycyny Wewnetrznej|August 23, 2003
[Cardiac involvement in systemic autoimmune disease]Jerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|April 24, 2003
Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarctionJerzy Dropiński, Wojciech Szczeklik, Paweł Rubiś, et al.
Kardiologia Polska|September 29, 2009
Assessment of resting perfusion defect in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography with contrast-enhanced magnetic resonance imagingMaria Olszowska, Magdalena Kostkiewicz, Piotr Podolec, et al.
European Heart Journal. Case Reports|May 17, 2023
Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patientKrystian Mróz, Paweł Rubiś, Piotr Podolec, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 2, 2021
Sacubitril/valsartan for heart failure with reduced ejection fraction: A first real-life observational study in PolandMałgorzata Lelonek, Sylwia Wiśniowska-Śmiałek, Paweł Rubiś, et al.
Kardiologia Polska|January 17, 2024
Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac SocietyMałgorzata Lelonek, Agnieszka Pawlak, Ewa Straburzyńska-Migaj, et al.
Pageof 9